Journal: bioRxiv
Article Title: Proteome-Wide Serology Identifies Secreted IgD against RSV Fusion Glycoprotein as a Signature of Broadly Elevated Antibody Response
doi: 10.64898/2026.11.03.764056
Figure Lengend Snippet: (A) Positive control demonstrating that post-iRSVF protein (0.5 µg/well) is coated onto the high-binding immunoassay microplates. Two tryptic RSVF peptides were measured, with a BSA peptide was presented as a loading control. (B) Negative control demonstrating the lack of non-specific binding of NISTmAb 8671 monoclonal antibody (1 µg/well) to the microplates coated with PBS and blocked with BSA (C) ProWiSe assays revealed that NISTmAb (1 µg/well) was enriched 640-fold with post-iRSVF protein (0.5 µg/well) relative to the negative control. (D) As an additional positive control, SARS-CoV-2 RBD protein (0.5 µg/well) enriched IgG1 antibodies from a pool of convalescent human sera (20 µL/well), as previously reported . NISTmAb, an IgG1 antibody, shares a unique tryptic peptide, GPSVFPLAPSSK, with endogenous human IgG1. (E) RSV-specific polyclonal antibodies were enriched from 80 maternal sera samples using an RSV post-iRSVF antigen, with three matched no-antigen negative controls. (F) For comparison, SARS-CoV-2-specific polyclonal antibodies were enriched with an RBD antigen from 10 PCR-confirmed convalescent plasma samples (+) and 5 pre-pandemic negative plasma (-). All IA enrichments and trypsin digestions (A-F) were completed onto a single microplate, and nanoLC-MS/MS with label-free MS1 quantification were used for analysis. *indicated statistically significant isotypes or subclasses determined using Bonferroni-adjusted 1-tail Mann-Whitney U test P -values < 0.0063. LOD levels were calculated in positive samples based on detectable peaks of the light endogenous peptides with a signal-to-noise ratio>3 for the combined MS1 intensity of a precursor and M+1 forms. Concentrations below LOD were adjusted to the LOD levels. PBS group levels below LOD are presented to demonstrate the variability of non-specific binding for all isotypes. PBS, no-antigen negative control with PBS buffer; RSVF, postfusion RSVF expressed in baculovirus-insect cells; RBD (+), Receptor binding domain of the spike glycoprotein SARS-CoV-2; RBD(-), no-antigen negative control with PBS buffer.
Article Snippet: High-binding 96-well polystyrene microplates (#655074, Greiner Bio-One, Monroe, NC) were coated overnight with recombinant antigen proteins in PBS: the initial experiments with untargeted DDA MS utilized 0.5 μg antigen/well, while the subsequent experiments with the targeted SRM and untargeted DIA measurements included 0.3 μg antigen/well.
Techniques: Positive Control, Binding Assay, Control, Negative Control, Nonspecific Binding, Comparison, Clinical Proteomics, Tandem Mass Spectroscopy, Analysis, MANN-WHITNEY